| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.29 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |